日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In Situ Sustained Delivery of Tumor Cell-Derived Extracellular Nanovesicles With Oncolytic Adenoviruses for Potentiating Cancer Immunotherapy.

利用溶瘤腺病毒原位持续递送肿瘤细胞来源的细胞外纳米囊泡以增强癌症免疫疗法。

Wang Tianye, Zhao Sheng, Ji Zao, He Zhonggui, Cheng Zhenguo, Gu Zhen, Zhang Yuqi, Sun Jin, Liu Funan, Sun Mengchi

An exosome-inspired docetaxel prodrug nanoplatform for potent STING activation and synergistic chemoimmunotherapy.

一种受外泌体启发的多西他赛前药纳米平台,可有效激活 STING 并实现协同化疗免疫疗法。

Wang Xinying, Zhang Xianlu, Jiao Zixuan, Ning Shipeng, Wang Hanping, Liu Hui, He Lifen, Li Haonan, Li Mingzhong, Wang Kaiyuan, Pan You, He Zhonggui

ROS-responsive transmembrane peptide-antibody conjugate eyedrops for the non-invasive treatment of choroidoretinopathy

用于非侵入性治疗脉络膜视网膜病变的ROS响应性跨膜肽-抗体偶联物滴眼液

Qu, Lihang; Lu, Tu; Tan, Jun; Chen, Xinzhao; Tian, Tian; Liu, Shixiang; Gong, Yajun; Jiang, Zhihao; He, Zhonggui; Sun, Peng; Sun, Jin; Ma, Xiaoli; Gu, Ruidong

Rational engineering of cholesterol-modified prodrug nanoassemblies for improving the tumor selectivity and safety of mitoxantrone

通过合理设计胆固醇修饰的前药纳米组装体来提高米托蒽醌的肿瘤选择性和安全性

Zhang, Bowen; Liu, Wenyuan; Liu, Jinrui; Huang, Minglong; Li, Yaqiao; Zhao, Erwei; Zhang, Lurong; Shi, Xianbao; Sun, Jin; He, Zhonggui; Li, Lingxiao; Sun, Bingjun

Modification-Response Integrated Modules Driven Cyclization-Dependent Prodrug Self-Assembly for Reshaping Pro-Apoptotic Tumor Redox Homeostasis

修饰-响应集成模块驱动的环化依赖性前药自组装用于重塑促凋亡肿瘤氧化还原稳态

Sun, Yixin; Zuo, Shiyi; Zang, Wenfeng; Li, Lingxiao; Shi, Xianbao; Li, Mingzhong; He, Zhonggui; Sun, Bingjun; Sun, Jin

One-Stone-Two-Birds Carrier-Free Nano-Cocktail Enables Synergistic Eradication of Cancer Cells/Stem Cells in Breast Cancer Treatment

一种无需载体的纳米鸡尾酒疗法可实现乳腺癌治疗中癌细胞/干细胞的协同清除。

Zhao, Tongyao; Chen, Yao; Yuan, Haimeng; Yang, Shuqian; Zhang, Hongyuan; Wang, Yuequan; Zhang, Shenwu; Chen, Qin; Sun, Jin; He, Zhonggui; Luo, Cong

Galloylated liposomes enable targeted drug delivery by overcoming protein corona shielding.

没食子酰化脂质体能够克服蛋白质冠状屏蔽效应,实现靶向药物递送

Li Jinbo, Yu Jiang, Song Jia, Zhang Yingxi, Li Ning, Wang Zhaomeng, Qin Meng, Zhao Mingming, Zhang Baoyue, Huang Ruiping, Zhou Shuang, Liu Yubo, He Zhonggui, Liu Hongzhuo, Dan Liu, Wang Yongjun

A chemotherapy nano-booster unlocks wider therapeutic window for prostate cancer treatment

化疗纳米增效剂为前列腺癌治疗开辟了更宽的治疗窗口

Liao, Rui; Wang, Yuequan; Lin, Ziqi; Wang, Yuting; Zhang, Hongyuan; Chen, Qin; Zhang, Shenwu; Sun, Jin; He, Zhonggui; Luo, Cong

Engineered platelet-derived exosomal spheres for enhanced tumor penetration and extended circulation in melanoma immunotherapy

工程化血小板衍生外泌体球体可增强黑色素瘤免疫治疗中的肿瘤渗透性和延长循环时间

Zhao, Jian; Lv, Xinyan; Lu, Qi; Wang, Kaiyuan; Du, Lili; Fan, Xiaoyuan; Sun, Fei; Liu, Fengxiang; He, Zhonggui; Ye, Hao; Sun, Jin

Erratum: Author correction to "Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors" [Acta Pharm Sin B 12 (2022) 952-966]

勘误:作者对“由二肽基光敏衍生物和缺氧激活的喜树碱前药组成的结构明确的串联响应纳米组装体对抗原发性和转移性乳腺肿瘤”[Acta Pharm Sin B 12 (2022) 952-966]进行了更正。

Sun, Mengchi; Jiang, Hailun; Liu, Tian; Tan, Xiao; Jiang, Qikun; Sun, Bingjun; Zheng, Yulong; Wang, Gang; Wang, Yang; Cheng, Maosheng; He, Zhonggui; Sun, Jin